Live from the NIH registry
Studies recruiting near Brownsville right now
Top 25 of 63 recruiting studies, sorted by proximity — each links to its official registry page
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
Non-alcoholic Fatty Liver Disease
Phase 3
Interventional 1,250 participants sought
GSK Investigational Site — Brownsville, Texas (7.1 mi)
· Sponsor: GlaxoSmithKline
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Phase 3
Interventional 762 participants sought
89bio Clinical Study Site — Brownsville, Texas (7.1 mi)
· Sponsor: 89bio, Inc.
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)
Irritable Bowel Syndrome
Phase 2
Interventional 420 participants sought
GSK Investigational Site — Harlingen, Texas (19.9 mi)
· Sponsor: GlaxoSmithKline
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
Metabolic Dysfunction-associated Steatohepatitis
Phase 2
Interventional 160 participants sought
South Texas Research Institute (STRI) - Brownsville — Brownsville, Texas (7.1 mi)
· Sponsor: Eccogene
Stroke Thrombectomy and Aneurysm Registry
Stroke, Thromboses, Intracranial
N/A
Observational 40,000 participants sought
Valley Baptist Medical Center — Harlingen, Texas (19.9 mi)
· Sponsor: Medical University of South Carolina
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Phase 3
Interventional 1,350 participants sought
89bio Clinical Study Site — Brownsville, Texas (7.1 mi)
· Sponsor: 89bio, Inc.
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Metabolic Dysfunction Associated Steatohepatitis
Phase 3
Interventional 1,590 participants sought
South Texas Research Institute - Brownsville — Brownsville, Texas (7.1 mi)
· Sponsor: Boehringer Ingelheim
The Pivotal Study of RapidPulseTM Aspiration System
Acute Ischemic Stroke
N/A
Interventional 170 participants sought
Valley Baptist Medical Center - Harlingen — Harlingen, Texas (19.9 mi)
· Sponsor: RapidPulse, Inc
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Overweight, Prediabetic State
Phase 3
Interventional 2,001 participants sought
Headlands Horizons, LLC dba Headlands Research-Brownsville — Brownsville, Texas (7.1 mi)
· Sponsor: Eli Lilly and Company
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
Moderately to Severely Active Ulcerative Colitis
Phase 3
Interventional 350 participants sought
Cano Medical Center — Harlingen, Texas (19.9 mi)
· Sponsor: Hoffmann-La Roche
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
COPD (Chronic Obstructive Pulmonary Disease)
Phase 3
Interventional 5,000 participants sought
Research Site — Brownsville, Texas (7.1 mi)
· Sponsor: AstraZeneca
A Study to Evaluate Solrikitug in Participants With COPD (ZION)
COPD
Phase 2
Interventional 171 participants sought
Proactive RGV — Brownsville, Texas (7.1 mi)
· Sponsor: Uniquity One (UNI)
Prospective Study to Assess a Diagnostic Aid for Cancer
Cancer
N/A
Observational 2,450 participants sought
Texas Digestive — Harlingen, Texas (19.9 mi)
· Sponsor: Harbinger Health
To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL
Peripheral T Cell Lymphoma
Phase 3
Interventional 504 participants sought
Valley Cancer Associates — Harlingen, Texas (19.9 mi)
· Sponsor: Acrotech Biopharma Inc.
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Diabetes Mellitus, Type 2, Hypertension
Phase 3
Interventional 11,800 participants sought
South Texas Research Institute - Brownsville — Brownsville, Texas (7.1 mi)
· Sponsor: Boehringer Ingelheim
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Obesity, Overweight
Phase 3
Interventional 3,003 participants sought
AURORA-1 Clinical Site — Brownsville, Texas (7.1 mi)
· Sponsor: Ascletis Pharma (China) Co., Limited
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
Metabolic Dysfunction-Associated SteatoHepatitis (MASH)
Phase 2
Interventional 120 participants sought
South Texas Research Institute (STRI) - Brownsville — Brownsville, Texas (7.1 mi)
· Sponsor: Regeneron Pharmaceuticals
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Carcinoma, Renal Cell, Advanced Renal Cell Carcinoma
Phase 1, Phase 2
Interventional 224 participants sought
Texas Oncology - Central South — Harlingen, Texas (19.9 mi)
· Sponsor: Pfizer
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Breast Cancer, Metastatic Breast Cancer
Phase 3
Interventional 404 participants sought
Texas Oncology - Harlingen — Harlingen, Texas (19.9 mi)
· Sponsor: BriaCell Therapeutics Corporation
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
Atrial Fibrillation (AF)
Phase 3
Interventional 15,364 participants sought
PanAmerican Clinical Research — Brownsville, Texas (7.1 mi)
· Sponsor: Regeneron Pharmaceuticals
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis
Phase 3
Interventional 980 participants sought
Valley Institute of Research - Site Number: 8400004 — Harlingen, Texas (19.9 mi)
· Sponsor: Sanofi
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
Chronic Obstructive Pulmonary Disease
Phase 3
Interventional 942 participants sought
Valley Institute of Research- Site Number : 8400118 — Harlingen, Texas (19.9 mi)
· Sponsor: Sanofi
Pharmacogenetics of the Response to GLP-1 in Mexican-Americans With Prediabetes
PreDiabetes
Phase 4
Interventional 300 participants sought
UTHealth Clinical Research Unit (CRU) at UT Brownsville — Brownsville, Texas (7.1 mi)
· Sponsor: The University of Texas Health Science Center, Houston
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
Non-alcoholic Fatty Liver Disease
Phase 3
Interventional 1,200 participants sought
GSK Investigational Site — Brownsville, Texas (7.1 mi)
· Sponsor: GlaxoSmithKline
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
Type 2 Diabetes
Phase 3
Interventional 600 participants sought
South Texas Research Institute - Brownsville — Brownsville, Texas (7.1 mi)
· Sponsor: Boehringer Ingelheim